Early Gift Nifty trends indicate that, following the Niftys 4.51% spike at the end of October, the Indian stock market is anticipated to start dull on.

US FDA grants priority review for Keytruda & Keytruda Qlex, each in combination with Padcev, for certain patients with muscle-invasive bladder cancer: Rahway, New Jersey Friday, O ...

Biochemist Kary Mullis says he was driving from the Bay Area to his cabin in Mendocino in 1983 when suddenly, like a bolt of lightning out of the California sky, he came up with a way to pinpoint a ...

BOSTON and LONDON, Oct. 09, 2025 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology company developing novel payload antibody drug conjugates (ADCs), today announced ...

Sanofi has bolstered its immuno-oncology pipeline with a $1 billion agreement to acquire Amunix Pharma of the US – its fourth bolt-on deal of 2021. South San Francisco-based Amunix specialises in ...

Jazz Pharma has bolstered its pipeline of cancer drugs through a $1.3 billion licensing agreement with Werewolf Therapeutics that adds its first immuno-oncology candidate. The Dublin-based pharma is ...

TORONTO, Oct. 23, 2025 /PRNewswire/ - Apotex Inc. ("Apotex" or the "Company"), the largest Canadian-based pharmaceutical company, today announced that Health Canada has granted a Notice of Compliance ...

Our Immuno-Oncology Program is internationally recognized for contributions to the biologic treatment of cancer using cytokines (IL-2,1 FN), targeted immunotherapy (CTLA4 and PD1 antibodies), vaccines ...

Xevinapant is an orally bioavailable antagonist of select members of the inhibitor of apoptosis protein (IAP) family. Despite promising phase II data, combining xevinapant with chemoradiotherapy (CRT) ...

Department of Chemical and Biological Engineering, Rensselaer Polytechnic Institute, Troy, New York 12180, United States Department of Biological Sciences, Rensselaer Polytechnic Institute, 110 8th ...